Pharmaceutical Product Monograph: Lansoprazole & Domperidone SR Capsules
In the pharmaceutical industry, this is a Fixed-Dose Combination (FDC) that integrates a powerful Proton Pump Inhibitor (PPI) with a Prokinetic agent. As a pharmacist and manufacturer at Healthy Life Pharma, I define this as a “Total Gastric Management” SKU.
For your WHO-GMP facility in Mumbai, this combination is a top-tier B2B seller because it addresses both the chemical (acid) and mechanical (motility) aspects of digestive disorders.
Therapeutic Profile: Primary Indications
This combination is indicated for acid-peptic disorders where “acid reflux” is accompanied by “gastric fullness” or “nausea.”
| Indication | Clinical Context | Technical Rationale |
| GERD (Gastroesophageal Reflux Disease) | Gastroenterology | For patients where acid is rising into the esophagus and causing “heartburn.” |
| Dyspepsia (Indigestion) | General Medicine | For bloating, early satiety (feeling full too soon), and upper abdominal discomfort. |
| Peptic / Duodenal Ulcers | Gastroenterology | Used to heal ulcers while preventing the nausea often associated with them. |
| NSAID-Induced Gastritis | Orthopedics | Often co-prescribed with painkillers to protect the stomach and prevent nausea. |
Mechanism: The Dual-Action Synergy
This formulation works through a “chemical brake” and a “mechanical accelerator”:
Lansoprazole (The Acid Brake): It technically binds to the $H^+/K^+$-ATPase pump (the “Proton Pump”) in the gastric parietal cells. It stops the final step of acid production, providing long-lasting $pH$ elevation.
Domperidone (The Motility Accelerator): It is a Peripheral Dopamine ($D_2$) Antagonist. It increases the contractions of the stomach and intestines while strengthening the Lower Esophageal Sphincter (LES).
The Result: Domperidone pushes the food down into the small intestine faster, while Lansoprazole ensures that any liquid that does splash back up is not acidic enough to cause a burn.
The Pharmacist’s “Technical Warning”
The “30-Minute Rule”: This capsule must be taken on an empty stomach, strictly 30 minutes before breakfast. If taken with or after food, the Domperidone will not reach the small intestine in time to coordinate gastric emptying.
Cardiac Precaution: Domperidone has been technically linked to QT Prolongation (heart rhythm issues) at high doses. It should be used with caution in elderly patients.
The “Pellet” Integrity: These are usually Sustained Release (SR) or Delayed Release (DR) pellets inside a capsule. Patients must not crush or chew the capsule, as this would destroy the protective coating and cause the Lansoprazole to degrade in the stomach acid before it can work.
The Manufacturer’s Perspective: Technical & Export
From the CEO’s desk at Healthy Life Pharma / Healthy Inc:
The “Dual-Pellet” USP: In our Mumbai plant, we specialize in Multi-Particulate Systems. We fill the capsule with two types of pellets: Lansoprazole (Enteric Coated) and Domperidone (Sustained Release). On your digital marketplace, highlight this “Advanced Pellet Technology” for superior B2B recognition.
Stability in Mumbai: Lansoprazole is highly unstable in heat and moisture. We use Alu-Alu blistering for all exports. This is non-negotiable for maintaining the integrity of the enteric coating during shipment to Africa or Southeast Asia.
Market Positioning: Position this as your “Advanced GI Solution.” While plain Omeprazole is a commodity, the Lansoprazole + Domperidone FDC is a premium specialty product with higher margins in the private retail and pharmacy chain sectors.
Digital Advertisement: Use keywords like “Lansoprazole Domperidone WHO-GMP” and “Gastroprokinetic FDC India.” This will attract B2B buyers looking for high-quality alternatives to brands like Prevacid combos.